Alamar Biosciences (ALMR): Qiming funds report over 10% ownership stake
Rhea-AI Filing Summary
Alamar Biosciences, Inc. has a significant shareholder group associated with Qiming funds reporting ownership of its common stock, par value $0.0001 per share. As of a base of 69,311,186 shares outstanding as of April 30, 2026, Qiming Corporate GP VI, Ltd and related entities report beneficial ownership positions on a Schedule 13G.
Qiming Corporate GP VI, Ltd is reported as beneficially owning 7,066,573 shares, or 10.2% of the class, with sole voting and dispositive power, representing 6,881,410 shares held by Qiming Venture Partners VI, L.P. and 185,163 shares held by Qiming Managing Directors Fund VI, L.P., while disclaiming beneficial ownership except for proportionate pecuniary interests. Additional Qiming-related entities report sole voting and dispositive power over stakes of 1,605,645 shares (2.3%) and 1,922,329 shares (2.8%), also with similar beneficial ownership disclaimers.
Positive
- None.
Negative
- None.
Key Figures
Shares outstanding: 69,311,186 shares
Qiming Corporate GP VI, Ltd beneficial ownership: 7,066,573 shares (10.2%)
Qiming Venture Partners VI, L.P. holdings: 6,881,410 shares (9.9%)
+3 more
6 metrics
Shares outstanding
69,311,186 shares
Common stock outstanding as of April 30, 2026, per Form 10-Q
Qiming Corporate GP VI, Ltd beneficial ownership
7,066,573 shares (10.2%)
Sole voting and dispositive power over Alamar common stock
Qiming Venture Partners VI, L.P. holdings
6,881,410 shares (9.9%)
Shares of Alamar common stock with sole voting and dispositive power
Qiming Managing Directors Fund VI, L.P. holdings
185,163 shares (0.3%)
Alamar common stock with sole voting and dispositive power
Qiming Venture Partners VIII Investments, LLC holdings
1,605,645 shares (2.3%)
Alamar common stock with sole voting and dispositive power
Qiming Venture Partners VIII-HC, L.P. holdings
1,922,329 shares (2.8%)
Alamar common stock with sole voting and dispositive power
Key Terms
beneficial ownership, sole voting power, sole dispositive power, Schedule 13G, +2 more
6 terms
beneficial ownership financial
"disclaims beneficial ownership of such shares, except to the extent of its proportionate"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
sole voting power financial
"5 | Sole Voting Power 7,066,573.00 6 | Shared Voting Power 0.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power financial
"7 | Sole Dispositive Power 7,066,573.00 8 | Shared Dispositive Power 0.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Schedule 13G regulatory
"form_type":"SCHEDULE 13G"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
CUSIP Number financial
"(e) | CUSIP Number(s): 010911105"
A CUSIP number is a nine-character code that uniquely identifies a specific U.S. or Canadian stock, bond, or other security, similar to a barcode or a social-security number for a financial instrument. It matters to investors because it removes confusion between similar securities, ensures trades and settlements are applied to the correct issue, and helps locate official documents and transaction records quickly.
Joint Filing Agreement regulatory
"Exhibit 99.1 Joint Filing Agreement, dated as of August 11, 2026."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What percentage of Alamar Biosciences (ALMR) does Qiming Corporate GP VI, Ltd report owning?
Qiming Corporate GP VI, Ltd reports beneficial ownership of 7,066,573 shares of Alamar Biosciences, representing 10.2% of the common stock. This is based on 69,311,186 shares outstanding as of April 30, 2026, as reported in Alamar’s Form 10-Q.
What stakes in Alamar Biosciences (ALMR) are reported by Qiming’s VIII-series entities?
Qiming GP VIII, LLC and Qiming Venture Partners VIII Investments, LLC each report 1,605,645 shares, or 2.3% of Alamar Biosciences. Qiming GP VIII-HC, LLC and Qiming Venture Partners VIII-HC, L.P. each report 1,922,329 shares, or 2.8% of the company’s common stock.
What voting and dispositive powers over Alamar Biosciences (ALMR) stock do the Qiming entities report?
Each Qiming entity reports sole voting power and sole dispositive power over its respective block of Alamar shares, with zero shared voting or dispositive power. The specific share counts and percentages differ by entity but follow this same power structure.